{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:06:15Z","timestamp":1790539575781,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T00:00:00Z","timestamp":1690675200000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.revmed.2022.03.341","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T07:33:40Z","timestamp":1654328020000},"page":"487-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epstein-Barr Virus et lupus syst\u00e9mique\u00a0: quels liens\u00a0?"],"prefix":"10.1016","volume":"43","author":[{"given":"A.","family":"Enfrein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2022.03.341_bib0350","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","article-title":"Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden","volume":"15","author":"Danchenko","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2022.03.341_bib0355","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.revmed.2013.10.334","article-title":"Physiopathologie du lupus syst\u00e9mique: le point en 2014","volume":"35","author":"Mathian","year":"2014","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.revmed.2022.03.341_bib0360","doi-asserted-by":"crossref","first-page":"587380","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr Virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0365","doi-asserted-by":"crossref","first-page":"665718","DOI":"10.3389\/fimmu.2021.665718","article-title":"The CD8T Cell-Epstein-Barr Virus-B Cell Trialogue: a central issue in multiple sclerosis pathogenesis","volume":"12","author":"Veroni","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0370","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0375","first-page":"13","article-title":"Latent and lytic Epstein-Barr virus replication strategies","author":"Tsurumi","year":"2004","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0380","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/viro.1996.0325","article-title":"Activation oforiLyt,the Lytic Origin of DNA Replication of Epstein-Barr Virus, by BZLF1","volume":"220","author":"Schepers","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.revmed.2022.03.341_bib0385","first-page":"151","article-title":"EBV Persistence-Introducing the Virus","volume":"1","author":"Thorley-Lawson","year":"2015"},{"key":"10.1016\/j.revmed.2022.03.341_bib0390","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1074-7613(00)80493-8","article-title":"Is EBV Persistence In Vivo a Model for B Cell Homeostasis?","volume":"5","author":"Khan","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.revmed.2022.03.341_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000496","article-title":"The Dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output","volume":"5","author":"Hadinoto","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.revmed.2022.03.341_bib0400","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders","volume":"38","author":"Rezk","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0405","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1128\/JVI.03001-14","article-title":"Epstein-Barr Virus Type 2\u00a0latently infects T Cells, inducing an atypical activation characterized by expression of lymphotactic cytokines","volume":"89","author":"Coleman","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0410","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jix363","article-title":"Epstein-Barr Virus Type 2\u00a0Infects T Cells in healthy Kenyan children","volume":"216","author":"Coleman","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.revmed.2022.03.341_bib0415","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/JCM.44.5.1873-1874.2006","article-title":"Increasing incidence of severe Epstein-Barr Virus-related infectious mononucleosis: surveillance study","volume":"44","author":"Tattevin","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","article-title":"The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis","volume":"19","author":"Li","year":"2019","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.revmed.2022.03.341_bib0425","doi-asserted-by":"crossref","DOI":"10.1186\/ar4429","article-title":"Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus","volume":"16","author":"Hanlon","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2022.03.341_bib0430","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2022.03.341_bib0435","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/0961203320940029","article-title":"Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity","volume":"29","author":"Aygun","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2022.03.341_bib0440","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000214","article-title":"Strong viral associations with SLE among Filipinos","volume":"4","author":"Vista","year":"2017","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.revmed.2022.03.341_bib0445","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/03009742.2014.973061","article-title":"Antibodies to early EBV, CMV, and HHV6\u00a0antigens in systemic lupus erythematosus patients","volume":"44","author":"Rasmussen","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0450","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","article-title":"Are women with lupus at higher risk of HPV infection?","volume":"19","author":"Klumb","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2022.03.341_bib0455","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.revmed.2020.12.009","article-title":"Papillomavirus humain et lupus \u00e9ryth\u00e9mateux syst\u00e9mique","volume":"42","author":"David","year":"2021","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.revmed.2022.03.341_bib0460","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/v13020277","article-title":"Viral infections and systemic lupus erythematosus: new players in an old story","volume":"13","author":"Quaglia","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.revmed.2022.03.341_bib0465","article-title":"Development of systemic lupus erythematosus after infectious mononucleosis in a 64-year-old woman","volume":"8","author":"Wang","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.revmed.2022.03.341_bib0470","first-page":"1","article-title":"Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology","author":"Sternb\u00e6k","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.revmed.2022.03.341_bib0475","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2022.03.341_bib0480","first-page":"6","article-title":"Epstein-Barr Virus infection induces lupus autoimmunity","volume":"64","author":"Harley","year":"2006","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.revmed.2022.03.341_bib0485","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08916930500484849","article-title":"Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus","volume":"39","author":"Poole","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.revmed.2022.03.341_bib0490","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaut.2004.06.001","article-title":"Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies","volume":"23","author":"Sundar","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2022.03.341_bib0495","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2022.03.341_bib0500","first-page":"9","article-title":"The possible effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, membrane antigen, latent membrane protein-1, and -2A on systemic lupus erythematosus","author":"Tu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0505","doi-asserted-by":"crossref","first-page":"606936","DOI":"10.3389\/fimmu.2020.606936","article-title":"Epstein-Barr functional mimicry: pathogenicity of oncogenic latent membrane protein-1\u00a0in systemic lupus erythematosus and autoimmunity","volume":"11","author":"Munroe","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0510","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/iid3.119","article-title":"Mapping an epitope in EBNA-1\u00a0that is recognized by monoclonal antibodies to EBNA-1\u00a0that cross-react with dsDNA: Mapping a viral peptide mimic for dsDNA","volume":"4","author":"Yadav","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.revmed.2022.03.341_bib0515","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molimm.2021.01.013","article-title":"Antibodies to an Epstein Barr Virus protein that cross-react with dsDNA have pathogenic potential","volume":"132","author":"Singh","year":"2021","journal-title":"Mol Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0520","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/art.21682","article-title":"An altered immune response to Epstein-Barr nuclear antigen 1\u00a0in pediatric systemic lupus erythematosus","volume":"54","author":"McClain","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2022.03.341_bib0525","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2019.02619","article-title":"Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an Epstein-Barr Virus-derived antigenic site","volume":"10","author":"Csorba","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0530","unstructured":"Garzelli C, Manunta M, Incaprera M, Bazzichi A, Conaldi PG, Falcone G. Antibodies to histones in infectious mononucleosis n.d.:5."},{"key":"10.1016\/j.revmed.2022.03.341_bib0535","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000233180","article-title":"Auto-antibodies in infectious mononucleosis, as determined by ELISA","volume":"69","author":"Halbert","year":"1982","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0540","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/03009742.2012.665944","article-title":"Epstein-Barr virus early antigen diffuse (EBV-EA\/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients","volume":"41","author":"Draborg","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0545","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imm.12200","article-title":"Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA","volume":"141","author":"Fattal","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.revmed.2022.03.341_bib0550","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-215361","article-title":"Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals","author":"Jog","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2022.03.341_bib0555","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000015","article-title":"Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients","volume":"1","author":"Draborg","year":"2014","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.revmed.2022.03.341_bib0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002328","article-title":"Exhausted cytotoxic control of Epstein-Barr Virus in human lupus","volume":"7","author":"Larsen","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.revmed.2022.03.341_bib0565","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cellimm.2005.06.010","article-title":"Phenotypic and functional analysis of EBV-specific memory CD8\u00a0cells in SLE","volume":"235","author":"Berner","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6473204","article-title":"Impaired cytokine responses to Epstein-Barr Virus antigens in systemic lupus erythematosus patients","volume":"2016","author":"Draborg","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.revmed.2022.03.341_bib0575","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0961203306075800","article-title":"Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan","volume":"16","author":"Lu","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2022.03.341_bib0580","first-page":"1287","article-title":"Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus","volume":"172","author":"Kang","year":"2004","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.revmed.2022.03.341_bib0585","doi-asserted-by":"crossref","unstructured":"Moon UY, Park SJ, Oh ST, Kim W-U, Park S-H, Lee H, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res n.d.;6:8.","DOI":"10.1186\/ar1181"},{"key":"10.1016\/j.revmed.2022.03.341_bib0590","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00430-004-0230-5","article-title":"Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan","volume":"194","author":"Yu","year":"2005","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"10.1016\/j.revmed.2022.03.341_bib0595","first-page":"6599","article-title":"EBV and systemic lupus erythematosus: a new perspective","volume":"174","author":"Gross","year":"2005","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.revmed.2022.03.341_bib0600","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1073\/pnas.1514484112","article-title":"Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A","volume":"112","author":"Minamitani","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.revmed.2022.03.341_bib0605","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1073\/pnas.221439999","article-title":"Control of Epstein-Barr virus reactivation by activated CD40\u00a0and viral latent membrane protein 1","volume":"99","author":"Adler","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.revmed.2022.03.341_bib0610","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","article-title":"EBV-encoded latent membrane protein 1\u00a0cooperates with BAFF\/BLyS and APRIL to induce T Cell-independent Ig heavy chain class switching","volume":"171","author":"He","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0615","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1128\/JVI.79.8.4936-4943.2005","article-title":"Latent membrane protein 1\u00a0regulates STAT1\u00a0through NF- B-dependent interferon secretion in Epstein-Barr Virus-immortalized B cells","volume":"79","author":"Najjar","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0620","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of Dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.revmed.2022.03.341_bib0625","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.27408","article-title":"Epstein-Barr virus promotes interferon-\u03b1 production by plasmacytoid dendritic cells","volume":"62","author":"Quan","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2022.03.341_bib0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043317","article-title":"Toll-Like Receptor 7\u00a0stimulates the expression of Epstein-Barr Virus latent membrane protein 1","volume":"7","author":"Valente","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2022.03.341_bib0635","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0961203317753069","article-title":"Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus","volume":"27","author":"Han","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2022.03.341_bib0640","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2\u00a0implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2022.03.341_bib0645","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3389\/fimmu.2018.02198","article-title":"Epstein Barr Virus Interleukin 10\u00a0suppresses anti-inflammatory phenotype in human monocytes","volume":"9","author":"Jog","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2022.03.341_bib0650","unstructured":"Ding Y, He X, Liao W, Yi Z, Yang H, Xiang W. The expression of EBV-encoded LMP1\u00a0in young patients with lupus nephritis n.d.:6."},{"key":"10.1016\/j.revmed.2022.03.341_bib0655","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3892\/etm.2014.1578","article-title":"The expression of renal Epstein-Barr virus markers in patients with lupus nephritis","volume":"7","author":"Yu","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.revmed.2022.03.341_bib0660","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/09612033211010339","article-title":"EBV load is associated with cfDNA fragmentation and renal damage in SLE patients","volume":"30","author":"Truszewska","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2022.03.341_bib0665","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2022.03.341_bib0670","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019\u00a0Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2022.03.341_bib0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428190400002202","article-title":"Adoptive immunotherapy for EBV-associated malignancies","volume":"46","author":"Gottschalk","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2022.03.341_bib0680","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2002-01-0039","article-title":"Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection","volume":"100","author":"Savoldo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2022.03.341_bib0685","first-page":"3","article-title":"Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis","author":"Pender","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.revmed.2022.03.341_bib0345","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:45:19Z","timestamp":1759337119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0248866322000868"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.03.341","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr Virus et lupus syst\u00e9mique\u00a0: quels liens\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.03.341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}